News at a glance: Logging ’s effects, endangered abalone, and a contract for UC postdocs
CONSERVATION
Life can thrive in a partially logged forest, study finds
Forest
plants and animals can thrive in selectively logged areas
, calling into question their designation as degraded ecosystems, a study in Malaysia has found. An international team of researchers studied differences among an intact old forest, partly logged forest areas, and sites cleared for oil palm plantations, all of them in Sabah state on northern Borneo. The scientists used data—gathered over 12 years by the Stability of Altered Forest Ecosystems project, one of the world’s largest ecological studies—abou...
Source: ScienceNOW - December 15, 2022 Category: Science Source Type: news
J & J and Merck Ebola Vaccines Produce Lasting Antibodies in Children and Adults: Studies J & J and Merck Ebola Vaccines Produce Lasting Antibodies in Children and Adults: Studies
Ebola vaccines developed by Johnson& Johnson and Merck produced virus-fighting antibodies and appear to be safe in children and adults, according to data from two studies published on Wednesday.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - December 15, 2022 Category: Consumer Health News Tags: Infectious Diseases News Source Type: news
Africa: Prevail Part of Large Ebola Vaccine Study Conducted in West Africa That Publishes Promising Findings
[FrontPageAfrica] Monrovia -- The Partnership for Research on Vaccines and Infectious Diseases in Liberia (PREVAIL), a joint Liberia-United States clinical research partnership, is part of the Partnership for Research on Ebola Vaccinations (PREVAC), an international consortium that conducts research in West Africa. The PREVAC consortium (Liberia, Guinea, Mali, and Sierra Leone) includes scientists from PREVAIL, the French research organization Inserm, and from institutions in Africa, the United States, and the United Kingdom. The conso (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - December 15, 2022 Category: African Health Source Type: news
Ebola vaccine regimens safe, immunogenic in adults and children
NIH participated in international PREVAC consortium. (Source: National Institutes of Health (NIH) News Releases)
Source: National Institutes of Health (NIH) News Releases - December 14, 2022 Category: American Health Source Type: news
Uganda: Disappearing Ebola Outbreak Challenges Vaccine Testing
[Independent (Kampala)] December 05 marked 80 days of responding to the Ebola Virus Disease (EVD) outbreak in Uganda and seven days since the last confirmed case in one of the worst hit districts called Kasanda. A total of 36 contacts were actively being followed-up in four districts, a follow-up rate of 100% in the past 24 hours. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - December 13, 2022 Category: African Health Source Type: news
Africa: Ebola Trial Candidate Vaccines Arrive in Uganda in Record 79 Days After Outbreak Declared
[WHO] The first doses of one of the three candidate vaccines against Sudan ebolavirus arrived in Uganda yesterday. These will be evaluated in a clinical trial called the Solidarity Against Ebola or Tokomeza Ebola. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - December 10, 2022 Category: African Health Source Type: news
Uganda: First Batch of Ebola Vaccines Arrives in Uganda For Clinical Trials
[allAfrica] Cape Town -- Uganda has received a shipment of 1,200 Ebola vaccine doses from the World Health Organization today, writes Elias Biryambarema for Reuters. Three vaccine options - one from the University of Oxford and Serum Institute of India, another by the Sabin Vaccine Institute and a third by Merck & Co Inc. will be considered for use in the clinical trial. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - December 8, 2022 Category: African Health Source Type: news
‘Ebola Could Have Wiped Us All’: Slow Lockdown Haunts Uganda
The authorities hesitated to impose restrictions in the epicenter of the Ebola outbreak because of residual trauma from the Covid lockdown. Ebola then spread to the capital, killing dozens of Ugandans. (Source: NYT Health)
Source: NYT Health - December 8, 2022 Category: Consumer Health News Authors: Abdi Latif Dahir Tags: Uganda Ebola Virus Museveni, Yoweri Kyagulanyi Ssentamu, Robert (Bobi Wine) Deaths (Fatalities) Politics and Government Clinical Trials Vaccination and Immunization Source Type: news
Uganda: Minister Aceng, WHO, Make Final Assessments As Uganda Prepares to Start Ebola Vaccine Trials
[Nile Post] Minister of Health Jane Ruth Aceng and the World Health Organization (WHO) country representative Yonas Tegegn Woldemariam have made final assessments of the clinical trial base in Kampala, as the country prepares to start Ebola vaccine trials. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - November 28, 2022 Category: African Health Source Type: news
Uganda: WHO to Carry Out Clinical Trials for Three Ebola Vaccines in Uganda Next Week
[Nile Post] The World Health Organisation (WHO) has announced that Uganda will receive three Ebola vaccines for clinical trials next week. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - November 18, 2022 Category: African Health Source Type: news
Ebola Vaccine Candidates Expected to Be Shipped to Uganda Next Week: WHO Ebola Vaccine Candidates Expected to Be Shipped to Uganda Next Week: WHO
Three Ebola vaccine candidates for a planned clinical trial are expected to be shipped to Uganda next week, WHO Director-General Tedros Adhanom Ghebreyesus said on Wednesday.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - November 16, 2022 Category: Consumer Health News Tags: Infectious Diseases News Source Type: news
WHO: 1st Ebola vaccines to arrive in Uganda next week
The head of the World Health Organization says he expects the first doses of Ebola vaccine targeting the strain causing the current outbreak in Uganda to arrive in the country next week (Source: ABC News: Health)
Source: ABC News: Health - November 16, 2022 Category: Consumer Health News Tags: Health Source Type: news
Johnson & Johnson Rises to #2 in Ranking of Companies ’ Efforts to Expand Access to Medicines Worldwide
Everyone should have the opportunity to lead a healthy life. This requires that we advance equitable access to healthcare and address some of the world’s most devastating and neglected diseases.We are proud that Johnson & Johnson’s actions to expand access to our medicines and focus on addressing diseases that disproportionately impact people in lower- and middle-income countries has made us the 2nd-ranked company globally in the 2022 Access to Medicine Index.Our industry-leading performance marks an improvement, up from 3rd in 2021, and is the sixth consecutive time we are featured as a top three performer by the ...
Source: Johnson and Johnson - November 15, 2022 Category: Pharmaceuticals Source Type: news
What Do Health Workers in Uganda Need to End the Current Ebola Outbreak?
By Tracy Kobukindo ,
Nurse and advocate ; David Bryden,
Director of the Frontline Health Workers Coalition and senior policy and advocacy advisor at IntraHealth International
Tracy Kobukindo is a registered nurse and advocate in Uganda. She also serves as a Frontline Health Workers Coalition Regional Advisor, helping to guide the Coalition ’s advocacy messages and policy recommendations. Photo by Tracy Kobukindo.November 03, 2022Health workers in Uganda are now at the forefront of responding to another serious infectious disease. Last month the country declared an Ebola outbreak, caused by the Sudan species of th...
Source: IntraHealth International - November 3, 2022 Category: International Medicine & Public Health Authors: kseaton Tags: Policy & Advocacy Health Workers Nurses Source Type: news
Ebola spreads in Uganda as country waits for experimental vaccine
There is no known treatment for the new Sudan Ebola virus strain rapidly spreading in Uganda, but there’s hope an experimental vaccine could be going into arms in the next few weeks. (Source: CBC | Health)
Source: CBC | Health - October 29, 2022 Category: Consumer Health News Tags: News/The National Source Type: news
